Literature DB >> 26951606

Predictive performance of HAS-BLED risk score for long-term survival in patients with non-ST elevated myocardial infarction without atrial fibrillation.

Ming-Jer Hsieh1, Cheng-Hung Lee1, Chun-Chi Chen1, Shang-Hung Chang1, Chao-Yung Wang1, I-Chang Hsieh2.   

Abstract

BACKGROUND: Predictive value of the Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly, Drugs or alcohol use (HAS-BLED) score for clinical outcomes has been investigated in patients with and without atrial fibrillation. Many factors in the HAS-BLED model have been reported to be prognostic predictors in patients with post-myocardial infarction (MI). However, few studies have investigated the predictive value of HAS-BLED score on long-term survival in patients with post-MI.
METHODS: A total of 617 patients with non-ST elevation MI (NSTEMI) without atrial fibrillation were enrolled. The Thrombolysis In Myocardial Infarction (TIMI), Global Registry of Acute Coronary Events (GRACE), Can Rapid Risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE), and HAS-BLED risk scores were calculated for each patient.
RESULTS: The C-statistics of TIMI, GRACE, CRUSADE, and HAS-BLED scores for 3-year survival were 0.658, 0.749, 0.756, and 0.765, respectively. For 3-year survival prediction, GRACE, CRUSADE, and HAS-BLED scores, respectively demonstrated superior performance than TIMI score and there was no significant difference between these three scores (GRACE vs. TIMI: z=1.615, p=0.027; CRUSADE vs. TIMI: z=1.371, p=0.043; HAS-BLED vs. TIMI: z=1.899, p=0.014; CRUSADE vs. GRACE: z=0.078, p=0.234; HAS-BLED vs. GRACE: z=0.435, p=0.166; HAS-BLED vs. CRUSADE: z=0.353, p=0.181). Multivariate analysis showed left ventricular ejection fraction <40%, old age, stroke history, bleeding history, and abnormal renal and liver function were independent predictors for 3-year mortality.
CONCLUSIONS: HAS-BLED scoring system is similar to the GRACE and CRUSADE systems but better than TIMI system to predict long-term survival outcomes in patients with NSTEMI without atrial fibrillation. However, HAS-BLED score is easier to calculate than GRACE and CRUSADE scores.
Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRUSADE; GRACE; HAS-BLED; NSTEMI; Survival; TIMI

Mesh:

Year:  2016        PMID: 26951606     DOI: 10.1016/j.jjcc.2016.02.005

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  5 in total

1.  Utility of the HAS-BLED score for risk stratification of patients with acute coronary syndrome.

Authors:  Diego Castini; Simone Persampieri; Ludovico Sabatelli; Massimo Erba; Giulia Ferrante; Federica Valli; Marco Centola; Stefano Carugo
Journal:  Heart Vessels       Date:  2019-04-10       Impact factor: 2.037

2.  CRUSADE Score is Superior to Platelet Function Testing for Prediction of Bleeding in Patients Following Coronary Interventions.

Authors:  Junghee Bang; Sun Young Choi; Moo Hyun Kim; Victor Serebruany
Journal:  EBioMedicine       Date:  2017-06-01       Impact factor: 8.143

3.  Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Jun-Hua Shen; Hui-Min Wang; Kou-Long Zheng; Hui-He Lu; Qing Zhang
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

4.  Temporal Trends in the Prevalence, Treatment and Outcomes of Patients with Acute Coronary Syndrome at High Bleeding Risk.

Authors:  Ziad Arow; Tal Ovdat; Mustafa Gabarin; Alexander Omelchenko; Mony Shuvy; Tsafrir Or; Abid Assali; David Pereg
Journal:  Diagnostics (Basel)       Date:  2022-07-22

5.  Comparative performance of AnTicoagulation and Risk factors In Atrial fibrillation and Global Registry of Acute Coronary Events risk scores in predicting long-term adverse events in patients with acute myocardial infarction.

Authors:  Gökhan Çetinkal; Cüneyt Koçaş; Betül Balaban Koçaş; Şükrü Arslan; Okay Abacı; Osman Şükrü Karaca; Yalçın Dalgıç; Özgür Selim Ser; Kudret Keskin; Ahmet Yıldız; Sait Mesut Doğan
Journal:  Anatol J Cardiol       Date:  2018-08       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.